Investor Insight Westport’ innovative technologies and pioneered alternative fuel delivery systems offer a compelling case for investors looking to…
Here are some charts that reflect our areas of focus this week at XLU Leads with New High Even…
-
-
-
-
-
-
-
-
-
Investing
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol‘ or the ‘Company‘), a clinical-stage life sciences company focused on developing…
-
Newer Posts